Prediction of response to immune checkpoint inhibitor therapy using 18F-FDG PET/CT in patients with melanoma-Reference-Cited by-同舟云学术

Prediction of response to immune checkpoint inhibitor therapy using 18F-FDG PET/CT in patients with melanoma

Published:2019-07 Issue:29 Volume:98 Page:e16417
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Amrane Karim,Le Goupil Delphine,Quere Gilles,Delcroix Olivier,Gouva Sylvie,Schick Ulrike,Salaun Pierre-Yves,Abgral Ronan,Alavi Zarrin,Keromnes Nathalie,Querellou Solène

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference35 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

2. Oncology meets immunology: the cancer-immunity cycle;Chen;Immunity,2013

3. Pembrolizumab for treatment of refractory melanoma;Bagcchi;Lancet Oncol,2014

4. Nivolumab in previously untreated melanoma without BRAF mutation;Robert;N Engl J Med,2015

5. Cancer immunotherapy using checkpoint blockade;Ribas;Science,2018

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Whole-body bioluminescence imaging of T-cell response in PDAC models;Frontiers in Immunology;2023-07-11

2. Predictive value and accuracy of [18F]FDG PET/CT modified response criteria for checkpoint immunotherapy in patients with advanced melanoma;European Journal of Nuclear Medicine and Molecular Imaging;2023-05-04

3. Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based Immunotherapy;American Journal of Clinical Dermatology;2023-05

4. FDG PET/CT–based Response Assessment in Malignancies;RadioGraphics;2023-04-01

5. The influence of metastatic patterns and tumor load on therapeutic efficacy of immunotherapy in patients with metastatic melanoma as determined by quantitative PET-parameters using [18F]-fluorodeoxyglucose PET/computed tomography;Melanoma Research;2023-03-03